Prelude TherapeuticsPRLD
13F holders, Q3 2024 (September 30)70holders +9
15new positions
7sold out
3famous investors
$2.07avg. 13F price*
At the end of Q3 2024, 70 institutions reported holding Prelude Therapeutics Inc. (PRLD) in their 13F filings, up 9 from Q2 2024. 15 opened new positions and 7 sold out. The largest holders were Orbimed Advisors LLC ($22.6M), Baker Bros. Advisors LP ($21.0M) and Deerfield Management Company, L.P. ($7.8M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Prelude Therapeutics Inc.
- CUSIP
- 74065P101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $5.8M |
| Exits | 7 | $1.6M |
All 13F filers, Q2 2024 → Q3 2024: 3,590,224 shares bought and 1,742,491 shares sold, net +1,847,733 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 70 holders
| Orbimed Advisors LLC | 0.41% | No change | 10,909,256 | $22.6M |
| Baker Bros. Advisors LP | 0.22% | No change | 10,123,824 | $21.0M |
| Deerfield Management Company, L.P. | 0.13% | Reduce -8.9% | 3,766,120 | $7.8M |
| Boxer Capital, LLC | 0.17% | Reduce -33.5% | 1,708,187 | $3.5M |
| T. Rowe Price Associates Inc. | 0.00% | Add +23.1% | 1,097,599 | $2.3M |
| BlackRock, Inc. | 0.00% | — | 1,058,316 | $2.2M |
| Vanguard Group Inc. | 0.00% | Add +1.1% | 1,021,770 | $2.1M |
| ExodusPoint Capital Management, LP | 0.02% | New | 921,621 | $1.9M |
| Avidity Partners Management LP | 0.09% | New | 890,000 | $1.8M |
| Massachusetts Financial Services Co. | 0.00% | Add +5.2% | 549,530 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +8.2% | 391,716 | $811K |
| Marshall Wace, LLP | 0.00% | New | 359,137 | $743K |
| Morgan Stanley | 0.00% | Add +12.6% | 323,689 | $670K |
| State Street Corp. | 0.00% | Add +35.1% | 286,046 | $592K |
| T. Rowe Price Investment Management, Inc. | 0.00% | New | 281,583 | $583K |
| Renaissance Technologies | 0.00% | Reduce -4.7% | 196,900 | $408K |
| Bridgeway Capital Management, LLC | 0.01% | Add +42.5% | 176,100 | $365K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Add +885.2% | 174,979 | $362K |
| TD Asset Management Inc | 0.00% | No change | 160,652 | $341K |
| Millennium Management | 0.00% | New | 160,524 | $332K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +4.1% | 133,249 | $276K |
| Northern Trust Corp. | 0.00% | Reduce -14.7% | 106,377 | $220K |
| Goldman Sachs Group Inc. | 0.00% | Add +27.0% | 95,161 | $197K |
| Walleye Capital LLC | 0.00% | Add +446.2% | 83,175 | $172K |
| Acadian Asset Management LLC | 0.00% | Add +235.3% | 74,143 | $152K |
| Manufacturers Life Insurance Company, The | 0.00% | No change | 70,045 | $145K |
| Exchange Traded Concepts, LLC | 0.00% | Add +32.2% | 64,409 | $133K |
| Two Sigma Investments, LP | 0.00% | Add +32.0% | 56,933 | $118K |
| XTX Topco Ltd | 0.01% | New | 48,239 | $100K |
| Two Sigma Advisers, LP | 0.00% | Reduce -5.9% | 47,900 | $99K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 40,102 | $83K |
| Cerity Partners LLC | 0.00% | New | 32,875 | $68K |
| Dimensional Fund Advisors LP | 0.00% | Add +0.0% | 29,082 | $60K |
| Bank of New York Mellon Corp | 0.00% | Reduce -21.1% | 28,613 | $59K |
| Barclays PLC | 0.00% | Add +86.0% | 27,165 | $56K |
| Bank of America Corp. | 0.00% | Reduce -27.2% | 24,944 | $52K |
| HSBC Holdings PLC | 0.00% | Reduce -16.6% | 20,772 | $44K |
| Sherbrooke Park Advisers LLC | 0.01% | New | 20,048 | $41K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +40.1% | 17,293 | $36K |
| Nuveen Asset Management, LLC | 0.00% | No change | 16,797 | $35K |
| Jump Financial, LLC | 0.00% | New | 15,534 | $32K |
| Citadel Advisors | 0.00% | Reduce -51.5% | 15,225 | $32K |
| Deutsche Bank AG | 0.00% | No change | 14,618 | $30K |
| Rhumbline Advisers | 0.00% | Reduce -44.3% | 12,004 | $25K |
| Verition Fund Management LLC | 0.00% | New | 11,295 | $23K |
| Jane Street Group, LLC | 0.00% | Reduce -20.0% | 10,361 | $21K |
| Citigroup Inc. | 0.00% | Add +220.3% | 9,655 | $20K |
| Simplex Trading, LLC | 0.00% | New | 9,332 | $19K |
| FMR LLC | 0.00% | Reduce -20.4% | 7,618 | $16K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -10.6% | 7,271 | $15K |
| Corebridge Financial, Inc. | 0.00% | Reduce -0.6% | 7,049 | $15K |
| UBS Group AG | 0.00% | Reduce -35.8% | 7,016 | $15K |
| Wells Fargo & Company | 0.00% | Add +4.5% | 6,053 | $13K |
| JPMorgan Chase & Co. | 0.00% | Add +1.8% | 5,966 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -24.9% | 5,302 | $11K |
| Point72 (DIFC) Ltd | 0.00% | New | 5,206 | $11K |
| New York State Common Retirement Fund | 0.00% | Reduce -81.1% | 3,622 | $7K |
| Royal Bank of Canada | 0.00% | Reduce -2.9% | 2,855 | $6K |
| Legal & General Group Plc | 0.00% | No change | 962 | $2K |
| California State Teachers Retirement System | 0.00% | No change | 955 | $2K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 819 | $2K |
| Group One Trading LLC | 0.00% | New | 500 | $1K |
| Amalgamated Bank | 0.00% | No change | 334 | $1K |
| Russell Investments Group, Ltd. | 0.00% | Reduce -94.9% | 76 | $157 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 64 | $132 |
| HighMark Wealth Management LLC | 0.00% | No change | 50 | $104 |
| Sterling Capital Management LLC | 0.00% | — | 42 | $87 |
| Arax Advisory Partners | 0.00% | No change | 19 | $40 |
| Earned Wealth Advisors, LLC | 0.00% | New | 8 | $17 |
| Cwm, LLC | 0.00% | Reduce -54.5% | 10 | $0 |
"% of holder's portfolio" is PRLD's weight in each manager's 13F, not the share of Prelude Therapeutics Inc. the manager owns.